6th Clinical Study
Effect of a novel nutraceutical combination of EstroG-100 and γ-aminobutyric acid (GABA) in attenuating symptoms of menopause in healthy adult women
: a randomized double-blinded placebo-controlled study

Study Dose:
EstroG-100® 514mg + GABA 50mg per day

Study Duration:
5 weeks

No. of Participants:
80 (Placebo:39, Test:41)
Ref: Menopause, 32(11):1036-1045. (2025)
Summary
This study demonstrated that the combination of EstroG-100® and GABA provided early and progressive improvements in menopausal symptoms. Significant reductions in anxiety and stress were observed following the first intake (Day 0), while improvements in headache and mood changes were observed by Day 3. After 5 weeks of supplementation, significant improvements were observed in overall menopausal symptoms (GCS), mood state (POMS), sleep quality (PSQI), sexual function, and depressive symptoms. These findings suggest that EstroG-100® combined with GABA may provide comprehensive support for both physical and psychological menopausal symptoms, contributing to improved overall quality of life.


